Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02937506Phase 4Completed
Phase 4, randomised, double-blind trial of propofol in colon cancer, irritable bowel syndrome (IBS) and colonic polyps (2 arms), sponsored by Mount Carmel Health System. Primary endpoint: Patient Satisfaction at Day 0. Started Nov 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02937506.